Skip to content

Investigating the effect of hydroalcoholic extract of Stachys lvandulifolia on hot flashes in menopausal women

Investigating the effect of hydroalcoholic extract of Stachys lvandulifolia on hot flashes in menopausal women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240211060955N1
Enrollment
86
Registered
2024-04-21
Start date
2024-05-21
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hot flashes in menopausal women. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: Recipient of 250 mg oral capsule of mountain tea, three times a day for 4 weeks. Intervention 2: Control group: Recipient of 250 mg capsules (Avisel) three times a

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Iranian and resident of Yasouj Being literate in reading and writing Willing to participate in research Women aged 45-60 Duration of menopause at least 1 and at most 5 years Absence of menopause at ages younger than 40 years old Pap smear test is normal Complaining of hot flashes Not using tobacco and alcohol Not suffering from physical diseases Not suffering from mental diseases according to the statement of the research unit Not suffering from infectious and febrile diseases No unfortunate and stressful events in life in the past 6 months No depression, stress or severe anxiety No use of treatments such as hormone therapy, food supplements, medicinal plants containing phytoestrogens, etc. in the Previous 6 months for Relieving the side effects of menopause Not taking drugs that affect vasomotor symptoms such as veraliprid, clonidine within 3 months before entering Research No contraindications to hormone use Body mass index less than 30

Exclusion criteria

Exclusion criteria: Reluctance to continue participating in the research. Suffering from febrile diseases during the study Simultaneous participation in another clinical trial Hospitalization for any reason during the research period Occurrence of any possible complications during the research period Consumption of soy or its products during the study Failure to take the drug for 4 consecutive doses or 6 alternating doses. Occurrence of a severe stressful event during the study

Design outcomes

Primary

MeasureTime frame
Duration of hot flashes. Timepoint: One week before the start of the intervention and in the 2nd and 4th weeks after the intervention. Method of measurement: Daily hot flush registration form.;Intensity of hot flashes. Timepoint: One week before the start of the intervention and in the 2nd and 4th weeks after the intervention. Method of measurement: Daily hot flush registration form.;Number of hot flashes during the day. Timepoint: One week before the start of the intervention and in the 2nd and 4th weeks after the intervention. Method of measurement: Daily hot flush registration form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Heidary

Mashhad University of Medical Sciences

heidaryfatemeh01@gmail.com+98 51 3884 6734

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026